Myeloproliferatif Hastalıklarda Retinal Bulgular

Tatar, Olcay

doi:10.37783/CRJ-0348

Myeloproliferatif Hastalıklarda Retinal Bulgular

Olcay Tatar (Hacettepe Üniversitesi Göz Hastalıkları Anabilim Dalı, Türkiye)

Güncel Retina Dergisi

6 0

Yıl: 2023 Cilt: 7 Sayı: 2 Sayfa Aralığı: 112 - 115 Metin Dili: Türkçe DOI: 10.37783/CRJ-0348 İndeks Tarihi: 11-05-2023

Myeloproliferatif Hastalıklarda Retinal Bulgular

Öz:

Myeloproliferatif hastalıklarda (MPH) göz tutulumu sık ve retinadaki bulgular çeşitlidir. Retina tutulumu, hematolojik değişiklikler, artmış hiperviskozite ve mikro sirkülasyonun etkilenmesine bağlı ortaya çıkar. Oküler bulgu ve semptomlar, MPH tanısı konulmadan önce ortaya çıkabilir ve MPH tedavisi ile düzelebilir. Dolayısıyla, atipik bulgularla seyreden, tedaviye direnç gösteren olgularda, ayırıcı tanıda MPH düşünülmesi, altta yatan hastalığın erken tanısına ve uygun tedavisinin başlanmasına yol açarak hastalığın morbidite ve mortalitesini azaltacaktır. Bazı retina bulguları da asemptomatik seyredebileceği için MPH tanısı ile izlenen hastalar düzenli göz muayenesi ile takip edilmelidir

Anahtar Kelime:

Retinal Manifestations in Patients with Myeloproliferative Disorders

Öz:

Ocular involvement in myeloproliferative diseases (MPD) is common and retinal findings are various. Retinal manifestations are due to hematologic changes, microcirculatory alterations, and hyperviscosity of blood. Ocular findings might precede the diagnosis of MPD and might regress following treatment for MPD. Therefore, in cases with atypical retinal findings refractory to treatment, MPD must be kept in mind in the differential diagnosis. The early diagnosis of the underlying disease and its appropriate treatment will affect morbidity and mortality in these patients. Retinal findings might also be asymptomatic in patients with MPD. Patients with MPD must, therefore, have regular ocular examinations in follow-up.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik

1. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008; 22(1):14-22.
2. Tognon R, Gasparotto EP, Neves RP, Nunes NS, Ferreira AF, Palma PV, et al. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis. Hematol Oncol. 2012 Feb 2;5:2. doi: 10.1186/1756-8722-5-2.
3. Liisborg C, Hasselbalch HC, Sørensen TL. Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Cancers (Basel). 2020;12(3):573.
4. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F. Clinical Course of Essential Thrombocythemia in 147 Cases. Cancer. 1990; 66(3): 549–556.
5. Wautier, M.-P, El Nemer W, Gane P, Rain J.-D, Cartron J.-P, Colin Y, et al. Increased Adhesion to Endothelial Cells of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Laminin Alpha5 Chain and Lu/BCAM. Blood 2007:110(3): 894–901.
6. Rao K, Shenoy SB, Kamath Y, Kapoor S. Central retinal artery occlusion as a presenting manifestation of polycythaemia vera. BMJ Case Rep. 2016;2016: bcr2016216417.
7. Ahn BY, Choi KD, Choi YJ, Jea SY, Lee JE. Isolated monocular visual loss as an initial manifestation of polycythemia vera. J Neurol Sci. 2007;258(1–2):151–3.
8. Zhao PY, Abalem MF, Rao RC. A Flushed Face and Dilated Retinal Veins. JAMA Ophthalmol. 2018;136(12):1414–5.
9. Regensburger J, Rauchegger T, Loacher L. Falkner F, Feisritzer C, Teuchner B Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report. BMC Ophthalmol 2022;22(1):221
10. İ masawa M, Iijima H. Multiple retinal vein occlusions in essential thrombocythemia. Am J Ophthalmol. 2002;133(1):152-5
11. Liu M, Lee AG,Rice L, Lambert HM. Bilateral retinal vascular occlusive disease in essential thrombocythemia. Retina. 1999;19(6):563-4.
12. Strassman I, Silverstone BZ, Seelenfreund MH, Sheer A, Berson D. Essential thrombocythemia: a rare case of central retinal artery occlusion. Metab Pediatr Syst.Ophthalmol (1985)1991;14(1):18- 20.
13. Nobacht S, Cruysberg JR, Deutman AF. Peripheral retinal nonperfusion associated with essential thrombocytosis. Am J Ophthlmol. 1999;127(1):101-2.
14. Yoshizumi MO, Townsend-Pico W. Essential thrombocytopenia and central retinal vein occlusion with neovascular glaucoma. Am J Ophthalmol. 1996;121(6):728-30.
15. Montalto, M, Biolato M, Gallo A, Racco S, Marrone G, Manna,R, et al. Severe Giant Cell Arteritis Associated with Essential Thrombocythaemia. Int. J. Immunopathol. Pharmacol. 2010; 2384): 1271–1274.
16. Espinosa G, Font J, Muñoz-Rodríguez FJ, Cervera R, Ingelmo M. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol. 2002;21(4):309-13.
17. Binaghi M, Gaudric A, Farcet JP, Coscas G. Extensive bilateral retinal arteritis in a hypereosinophilic syndrome in a tuberculosis patient. Bull Soc Ophtalmol Fr. 1982;82(1):59-63.
18. Gupta OP, Zegere E, Maguire JI. Purtscher like retinopathy associated with hepereosinophilic syndrome. Retinal Cases Brief Rep. Spring 2009;3(2):193-6.
19. Jindahra P, Dejthevaporn C, Niparuck P, Waisayarat J, Cheecharoen P, Threetong T, et al. Atypical central retinal artery occlusion as the first presentation of POEMSsyndrome: a case report. BMC Neurol. 2018;18(1):64.
20. Carey AR, Jeyaseelan P. Peripheral retinal leakage in POEMS syndrome. Int J Retina Vitreous. 2021;7(1):6.
21. Dong Y, Yin D, Perez White BE, Guo Q, Pi Y, Wei S. Concurrent juxtapapillary hemorrage and optic disc edema as initial presentation of POEMS syndrome. Can J Ophthalmol. 2018;53(6): e233-e236
22. Carraro MC, Rossetti L, Gerli GC. Prevalence of Retinopathy in Patients with Anemia or Thrombocytopenia. Eur. J. Haematol. 2001; 67(4): 238–244.
23. Krishnan, R. Peripheral Retinal Neovascularization Associated with Polycythemia Rubra Vera. Jpn. J. Ophthalmol. 2009; 53(2): 188–189.
24. Kim MJ, Yu HG. Case of Bilateral Retinal Neovascularization Associated with Chronic Idiopathic Myelofibrosis. Korean J. Ophthalmol. 2010; 24(2):131-3.
25. Haskes C, Gagnon K. Retinal Manifestations of Idiopathic Myelofibrosis, a Hematologic Disorder. J. Am. Optom. Assoc. 1998;69(5): 319–328.
26. Dhasmana R, Prakash A, Gupta N, Verma SK. Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters. Ann Afr Med. 2016;15(3):97-103.
27. Yang HS, Joe SG, Kim JG, Park SH, Ko HS. Delayed Choroidal and Retinal Blood Flow in Polycythaemia Vera Patients with Transient Ocular Blindness: A Preliminary Study with Fluorescein Angiography. Br. J. Haematol. 2013;161(5): 745–747.
28. Willerslev A, Hansen MM, Klefter ON, Bjerrum OW, Hasselbalch HC, Clemmensen SN, et al. Non-invasive imaging of retinal blood flow in myeloproliferative neoplasms. Acta Ophthalmol. 2017;95(2):146-152.
29. Dapling RB, Snowden JA, West J, Talbot JF, Nelson ME, Greaves M. The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography. Clin Lab Haematol. 1996;18(4):277-9.
30. Havelius U, Berglund S, Falke P, Hindfelt B, Krakau,T. Impaired Dark Adaptation in Polycythemia. Improvement after Treatment. Acta. Ophthalmol. Scand. 2000;78(1): 53–57.
31. Rue KS, Hirsch, LK, Sadun AA. Impending Anterior Ischemic Optic Neuropathy with Elements of Retinal Vein Occlusion in a Patient on Interferon for Polycythemia Vera. Clin. Ophthalmol. 2012;6:1763–1765.
32. Tonz, MS, Rigamonti V, Iliev ME. Simultaneous, Bilateral Anterior Ischemic Optic Neuropathy (AION) in Polycythemia Vera: A Case Report. Klin. Monbl. Augenheilkd. 2008;225(5): 504–506.
33. Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Maguire MG. Reduced Foveolar Choroidal Blood Flow in Eyes with Increasing AMD Severity. Investig. Opthalmology Vis. Sci. 2005; 46(3):1033-8.
34. Bak M, Sørensen TL, Flachs EM, Zwisler AD, Juel K, Frederiksen H, et al. Age-Reated Macular Degeneration in Patients with Chronic Myeloproliferative Neoplasms. JAMA Ophthalmol. 2017;135(8):835-843.
35. Liisborg C, Nielsen MK, Hasselbalch HC, Sørensen TL. Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration. EClinicalMedicine. 2020 Sep 9;26:100526. doi: 10.1016/j.eclinm. 2020.100526.
36. Liisborg C, Skov V, Kjær L, Hasselbalch HC, Sørensen TL. Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation. EClinicalMedicine. 2021 Dec 25;43:101248. doi: 10.1016/j.eclinm.2021.101248.
37. Liisborg C, Skov V, Kjær L, Hasselbalch HC, Sørensen TL. Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system. Aging (Albany NY). 2021; 13(24): 25763-25777.
38. Liisborg C, Skov V, Kjær L, Hasselbalch HC, Lykke Sørensen T. Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers. PLoS One. 2022;17(6):e0269960.
39. Knapp AJ, Gartner S, Henkind P. Multiple myeloma and its ocular manifestations. Surv Ophthalmol. 1987;31(5):343-51.
40. Merz T, Marchesoni I, Caminiti G, Romanelli F. Efficacy of plasmapheresis as treatment for bilateral hyperviscosity syndrome related retinopathy in multiple myeloma. Eur J Ophthalmol. 2022;32(4):NP48-NP51.
41. Rao K, Murthy H, Muralidhar NS, Rani PK. Multiple myeloma masquerading as diabetic retinopathy. BMJ Case Rep. 2018;2018:bcr2017223485.
42. Omoti AE, Omoti CE. Ophthalmic manifestations of multiple myeloma. West Afr J Med. 2007;26(4):265-8.

APA	Tatar O (2023). Myeloproliferatif Hastalıklarda Retinal Bulgular. , 112 - 115. 10.37783/CRJ-0348
Chicago	Tatar Olcay Myeloproliferatif Hastalıklarda Retinal Bulgular. (2023): 112 - 115. 10.37783/CRJ-0348
MLA	Tatar Olcay Myeloproliferatif Hastalıklarda Retinal Bulgular. , 2023, ss.112 - 115. 10.37783/CRJ-0348
AMA	Tatar O Myeloproliferatif Hastalıklarda Retinal Bulgular. . 2023; 112 - 115. 10.37783/CRJ-0348
Vancouver	Tatar O Myeloproliferatif Hastalıklarda Retinal Bulgular. . 2023; 112 - 115. 10.37783/CRJ-0348
IEEE	Tatar O "Myeloproliferatif Hastalıklarda Retinal Bulgular." , ss.112 - 115, 2023. 10.37783/CRJ-0348
ISNAD	Tatar, Olcay. "Myeloproliferatif Hastalıklarda Retinal Bulgular". (2023), 112-115. https://doi.org/10.37783/CRJ-0348

APA	Tatar O (2023). Myeloproliferatif Hastalıklarda Retinal Bulgular. Güncel Retina Dergisi, 7(2), 112 - 115. 10.37783/CRJ-0348
Chicago	Tatar Olcay Myeloproliferatif Hastalıklarda Retinal Bulgular. Güncel Retina Dergisi 7, no.2 (2023): 112 - 115. 10.37783/CRJ-0348
MLA	Tatar Olcay Myeloproliferatif Hastalıklarda Retinal Bulgular. Güncel Retina Dergisi, vol.7, no.2, 2023, ss.112 - 115. 10.37783/CRJ-0348
AMA	Tatar O Myeloproliferatif Hastalıklarda Retinal Bulgular. Güncel Retina Dergisi. 2023; 7(2): 112 - 115. 10.37783/CRJ-0348
Vancouver	Tatar O Myeloproliferatif Hastalıklarda Retinal Bulgular. Güncel Retina Dergisi. 2023; 7(2): 112 - 115. 10.37783/CRJ-0348
IEEE	Tatar O "Myeloproliferatif Hastalıklarda Retinal Bulgular." Güncel Retina Dergisi, 7, ss.112 - 115, 2023. 10.37783/CRJ-0348
ISNAD	Tatar, Olcay. "Myeloproliferatif Hastalıklarda Retinal Bulgular". Güncel Retina Dergisi 7/2 (2023), 112-115. https://doi.org/10.37783/CRJ-0348